Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(21 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig1 Annane IntJInterMobileTech2019 13-4.png|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Anx1 WHO 2020 2020.5.png|240px]]</div>
'''"[[Journal:Virtualization-based security techniques on mobile cloud computing: Research gaps and challenges|Virtualization-based security techniques on mobile cloud computing: Research gaps and challenges]]"'''
'''"[[Journal:Laboratory testing for coronavirus disease (COVID-19) in suspected human cases|Laboratory testing for coronavirus disease (COVID-19) in suspected human cases]]"'''


The principle constraints of mobile devices are their limited resources, including processing capability, storage space, and battery life. However, [[cloud computing]] offers a means of vast computing resources and services. With it a new idea emerged, the inclusion of cloud computing into mobile devices such as smartphones, tablet, and other personal digital assistants (PDA) to augment their capacities, providing a robust technology called mobile cloud computing (MCC). Although MCC has brought many advantages to mobile users, it also still suffers from the security and privacy issues of data while hosted on virtual machines (VM) on remote cloud’s servers. Currently, the eyes of security experts are turned towards the virtualization-based security techniques used either on the cloud or on mobile devices. The new challenge is to develop secure methods in order to authenticate highly sensitive digital content. ('''[[Journal:Virtualization-based security techniques on mobile cloud computing: Research gaps and challenges|Full article...]]''')<br />
This document provides interim guidance to [[Laboratory|laboratories]] and stakeholders involved in [[COVID-19]] virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for [[Middle East respiratory syndrome]] (MERS) coronavirus. [[Information]] on human [[infection]] with the COVID-19 virus is evolving and the [[World Health Organization]] (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. ('''[[Journal:A security review of local government using NIST CSF: A case study|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Building open access to research (OAR) data infrastructure at NIST|Building open access to research (OAR) data infrastructure at NIST]]
: ▪ [[Journal:One tool to find them all: A case of data integration and querying in a distributed LIMS platform|One tool to find them all: A case of data integration and querying in a distributed LIMS platform]]
: ▪ [[Journal:Development of standard operating protocols for the optimization of Cannabis-based formulations for medical purposes|Development of standard operating protocols for the optimization of Cannabis-based formulations for medical purposes]]
: ▪ [[Journal:What is the "source" of open-source hardware?|What is the "source" of open-source hardware?]]
: ▪ [[Journal:Next steps for access to safe, secure DNA synthesis|Next steps for access to safe, secure DNA synthesis]]
: ▪ [[Journal:From command-line bioinformatics to bioGUI|From command-line bioinformatics to bioGUI]]

Revision as of 15:46, 23 March 2020

Anx1 WHO 2020 2020.5.png

"Laboratory testing for coronavirus disease (COVID-19) in suspected human cases"

This document provides interim guidance to laboratories and stakeholders involved in COVID-19 virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for Middle East respiratory syndrome (MERS) coronavirus. Information on human infection with the COVID-19 virus is evolving and the World Health Organization (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. (Full article...)

Recently featured:

One tool to find them all: A case of data integration and querying in a distributed LIMS platform
What is the "source" of open-source hardware?
From command-line bioinformatics to bioGUI